# A First-in-Human Study of ZE66-0205 in Healthy Volunteers

> **NCT07735728** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Eilean Therapeutics** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Volunteers (HV)

## Interventions

- **DRUG:** ZE66-0205
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07735728
- **Lead sponsor:** Eilean Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2027-08-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735728, "A First-in-Human Study of ZE66-0205 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07735728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*